Companies › Intellia Therapeutics
2 active drug programs in 4 registered trials: 3 Phase 3, 1 Phase 1; Immunology, Neurology, Cardiovascular; next expected readout May 2027.
Open in Phaseline: competitors, likelihood bands and readouts Company report
| Drug | Target | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|
| NTLA-2002 | – | Phase 3 | Hereditary Angioedema | May 2027 |
| nexiguran ziclumeran (NTLA-2001) in vivo CRISPR/Cas9 gene editing targeting TTR gene | TTR | Phase 3 | Neuromuscular Disease; Transthyretin Amyloidosis (ATTR) With Cardiomyopathy | Jul 2027 |
| Registry id | Drug | Phase | Conditions | Area | Expected readout |
|---|---|---|---|---|---|
| NCT05120830 | NTLA-2002 | Phase 1 | Hereditary Angioedema | Immunology | May 2027 |
| NCT06672237 | nexiguran ziclumeran (NTLA-2001) | Phase 3 | Neuromuscular Disease | Neurology | Jul 2027 |
| NCT06634420 | NTLA-2002 | Phase 3 | Hereditary Angioedema | Immunology | Sep 2027 |
| NCT06128629 | nexiguran ziclumeran (NTLA-2001) | Phase 3 | Transthyretin Amyloidosis (ATTR) With Cardiomyopathy | Cardiovascular | Dec 2027 |
Cash and short-term investments of $474m on 2026-09-30; operating cash outflow about $384m a year; runway about 15 months at that burn, to Dec 2027; 3 of 3 coming phase 2-3 readouts fall inside that runway
Press releases filed as 8-K in the last year:
Held by 6 of the 39 life-science funds Phaseline follows through their 13F filings. Who holds what.
Alnylam Pharmaceuticals AstraZeneca Novo Nordisk Neurimmune Eidos Therapeutics, a BridgeBio company Ionis Pharmaceuticals Qilu Pharmaceutical
Eidos Therapeutics, a BridgeBio company Abeona Therapeutics Supergene Kedrion Cabaletta Bio
Pipelines of the same shape: areas, drug types, target families, stage and cash runway.
Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.